Breaking News Instant updates and real-time market news.

LNG

Cheniere Energy

$55.11

-1.16 (-2.06%)

, TELL

Tellurian

$9.19

0.3 (3.37%)

13:55
02/27/18
02/27
13:55
02/27/18
13:55

House Comittee on Natural Resources to hold a hearing

The Subcommittee on Energy and Mineral Resources holds a hearing entitled, "Liquefied Natural Gas and U.S. Geopolitics" with Meg Gentle, CEO of Tellurian and Chris Smith, SVP of Cheniere Energy on February 27 at 2 pm. Webcast Link

LNG

Cheniere Energy

$55.11

-1.16 (-2.06%)

TELL

Tellurian

$9.19

0.3 (3.37%)

  • 27

    Feb

  • 27

    Feb

  • 27

    Feb

  • 13

    Mar

  • 25

    Jun

LNG Cheniere Energy
$55.11

-1.16 (-2.06%)

02/02/18
SBSH
02/02/18
NO CHANGE
SBSH
Citi downgrades both NuStar Energy, NuStar GP on valuation
Citi analyst Faisel Khan earlier today downgraded both NuStar Energy (NS) and NuStar GP Holdings (NSH) to Neutral from Buy on valuation. The analyst keeps a $33 price target for NuStar Energy and $17 price target for NuStar GP. He believes Plains All American (PAA), Plains GP Holdings (PAGP) and Buckeye Partners (BPL) provide more upside at current valuation levels with exposure to the Port of Corpus Christi. Khan also raised his price target for Buy-rated Cheniere Energy (LNG) to $67 from $59 to incorporate Train 3.
01/04/18
STFL
01/04/18
INITIATION
Target $65
STFL
Buy
Cheniere Energy initiated with a Buy at Stifel
Stifel analyst Benjamin Nolan started Cheniere Energy with a Buy rating and $65 price target. The analyst believes the company can generate at least $6 per share in distributable cash flow when the full development of seven trains is online in 2020.
11/17/17
COWN
11/17/17
INITIATION
Target $56
COWN
Market Perform
Cheniere Energy initiated with a Market Perform at Cowen
Cowen analyst Sam Margolin started Cheniere Energy with a Market Perform rating and $56 price target. The analyst sees more upside in companies with projects yet to gain FERC approval.
09/26/17
BMOC
09/26/17
INITIATION
BMOC
Outperform
Cheniere Energy initiated at BMO Capital
As noted earlier, BMO Capital started coverage of Cheniere Energy with an Outperform rating and a $60 price target. Analyst Danilo Juvane estimates that the company will generate $6-$7 per share of discounted cash flow starting in 2021, "easily supporting a 10% long-term annual dividend growth rate," according to the analyst. Juvane also expects the company to benefit from what he calls its "streamlined cost structure" and "strong" global LNG demand.
TELL Tellurian
$9.19

0.3 (3.37%)

01/04/18
STFL
01/04/18
INITIATION
Target $16
STFL
Buy
Tellurian initiated with a Buy at Stifel
Stifel analyst Benjamin Nolan started Tellurian with a Buy rating and $16 price target. The analyst believes the company's strategy of selling portions of its Driftwood project to prospective gas buyers rather than leasing capacity under a tolling arrangement "dramatically" improves the odds of success.
12/14/17
GHSC
12/14/17
INITIATION
Target $14
GHSC
Buy
Tellurian initiated with a Buy at Seaport Global
Seaport Global analyst Sunil Sibal initiated Tellurian with a Buy and $14 price target. Sibal said Tellurian has unique approach to financing and building new LNG liquefaction and export capability in North America has a high likelihood of success as international LNG buyers start looking to source US shale plays.
11/17/17
COWN
11/17/17
INITIATION
Target $13.5
COWN
Outperform
Tellurian initiated with an Outperform at Cowen
Cowen analyst Sam Margolin started Tellurian with an Outperform rating and $13.50 price target. The analyst views the company as a "ground floor" Liquefied Natural Gas opportunity and sees the FERC decision as a likely positive catalyst.

TODAY'S FREE FLY STORIES

EQGP

EQT GP

$24.87

-0.25 (-1.00%)

, EQM

EQT Midstream Partners

$54.90

0.49 (0.90%)

14:02
07/16/18
07/16
14:02
07/16/18
14:02
Conference/Events
Rice Midstream to host special shareholder meeting »

Special Shareholder…

EQGP

EQT GP

$24.87

-0.25 (-1.00%)

EQM

EQT Midstream Partners

$54.90

0.49 (0.90%)

RMP

Rice Midstream

$18.16

0.16 (0.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 26

    Jul

CRSP

Crispr Therapeutics

$59.61

-6.13 (-9.32%)

14:01
07/16/18
07/16
14:01
07/16/18
14:01
Periodicals
Crispr Therapeutics tells CNBC does not use methods described in paper »

Crispr Therapeutics told…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$37.79

-0.22 (-0.58%)

14:00
07/16/18
07/16
14:00
07/16/18
14:00
Options
Bullish option play opened in Masco ahead of earnings »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CRSP

Crispr Therapeutics

$59.09

-6.65 (-10.12%)

13:55
07/16/18
07/16
13:55
07/16/18
13:55
Options
Crispr Therapeutics put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:50
07/16/18
07/16
13:50
07/16/18
13:50
General news
U.S. equities are up from earlier lows »

U.S. equities are up from…

ECA

Encana

$12.84

-0.4 (-3.02%)

13:45
07/16/18
07/16
13:45
07/16/18
13:45
Options
Encana call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Aug

  • 09

    Oct

ADS

Alliance Data

$220.17

-23.32 (-9.58%)

13:44
07/16/18
07/16
13:44
07/16/18
13:44
Technical Analysis
Technical Take: Alliance Data comes off the lows of the day »

Shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

CRM

Salesforce

$147.50

-0.18 (-0.12%)

13:39
07/16/18
07/16
13:39
07/16/18
13:39
Hot Stocks
Salesforce announces definitive agreement to acquire Datorama »

Salesforce has signed a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 16

    Aug

YELP

Yelp

$40.33

0.54 (1.36%)

13:35
07/16/18
07/16
13:35
07/16/18
13:35
Options
Yelp put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LBIX

Leading Brands

$1.62

-0.06 (-3.57%)

13:32
07/16/18
07/16
13:32
07/16/18
13:32
Hot Stocks
Leading Brands announces resolution of temporary non-compliance with Nasdaq rule »

Leading Brands announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STM

STMicroelectronics

$22.84

0.2 (0.88%)

13:25
07/16/18
07/16
13:25
07/16/18
13:25
Options
STMicroelectronics call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

13:25
07/16/18
07/16
13:25
07/16/18
13:25
Conference/Events
Stephens agricultural analyst to hold an analyst/industry conference call »

Agriculture, Chemicals,…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

, NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

13:23
07/16/18
07/16
13:23
07/16/18
13:23
Periodicals
Editas tells CNBC 'not specifically concerned about' Crisper study »

Editas Medicine (EDIT)…

EDIT

Editas Medicine

$36.20

-1.71 (-4.51%)

NTLA

Intellia Therapeutics

$30.55

-2.05 (-6.29%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$68.30

-0.33 (-0.48%)

13:19
07/16/18
07/16
13:19
07/16/18
13:19
Periodicals
CVS apologizes after store managers call police on black customer, AP says »

CVS Health is apologizing…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
07/16/18
07/16
13:17
07/16/18
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
07/16/18
07/16
13:16
07/16/18
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEGI

Pattern Energy

$17.84

0.75 (4.39%)

13:10
07/16/18
07/16
13:10
07/16/18
13:10
Options
Change of sentiment in Pattern Energy »

Change of sentiment in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:05
07/16/18
07/16
13:05
07/16/18
13:05
Conference/Events
The Brookings Institution to hold a conference »

7th Annual Municipal…

C

Citi

$69.22

2.22 (3.31%)

13:04
07/16/18
07/16
13:04
07/16/18
13:04
Hot Stocks
Citi reports June credit loss 2.60% vs. 2.78% last month »

Reports June 30-plus day…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Jul

  • 14

    Jan

  • 15

    Apr

  • 13

    Jul

  • 15

    Oct

ORMP

Oramed

$5.89

-0.08 (-1.34%)

13:02
07/16/18
07/16
13:02
07/16/18
13:02
Downgrade
Oramed rating change  »

B. Riley FBR downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

QDEL

Quidel

$69.21

0.03 (0.04%)

13:01
07/16/18
07/16
13:01
07/16/18
13:01
Hot Stocks
Quidel receives FDA clearance to market Solana Bordetella Complete Assay »

Quidel announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RRD

R.R. Donnelley

$5.53

-0.11 (-1.95%)

13:00
07/16/18
07/16
13:00
07/16/18
13:00
Options
4K RR Donnelley and Sons Aug 6 calls trade for 24c »

4K RR Donnelley and Sons…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:00
07/16/18
07/16
13:00
07/16/18
13:00
General news
Fed Chairman Powell's Monetary Policy testimony Tuesday won't break new ground »

Fed Chairman…

AMD

AMD

$16.85

0.575 (3.53%)

12:59
07/16/18
07/16
12:59
07/16/18
12:59
Hot Stocks
AMD jumps after analyst sees product transition to expand margins »

Shares of chip maker AMD…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORMP

Oramed

$5.89

-0.08 (-1.34%)

12:58
07/16/18
07/16
12:58
07/16/18
12:58
Downgrade
Oramed rating change  »

Oramed downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.